Cargando…

Impact of Proteinase 3 versus Myeloperoxidase Positivity on Risk of End-Stage Renal Disease in ANCA-Associated Glomerulonephritis Stratified by Histological Classification: A Population-Based Cohort Study

BACKGROUND: End-stage renal disease (ESRD) risk in patients with antineutrophil cytoplasmic antibody- (ANCA-) associated glomerulonephritis (ANCA-GN) according to ANCA serotype and stratified by histological classification has not been previously investigated. METHODS: Patients from the Norwegian Ki...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solbakken, Vilde, Fismen, Anne-Siri, Bostad, Leif, Bjørneklett, Rune
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966671/ https://www.ncbi.nlm.nih.gov/pubmed/29854025 http://dx.doi.org/10.1155/2018/3251517

Ejemplares similares

Prognosis and Histological Classification in Elderly Patients with ANCA-Glomerulonephritis: A Registry-Based Cohort Study
por: Bjørneklett, Rune, et al.
Publicado: (2018)

Prognostic Factors in Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis with Severe Glomerular Sclerosis: A National Registry-Based Cohort Study
por: Bjørneklett, Rune, et al.
Publicado: (2018)

Cancer in ANCA-Associated Glomerulonephritis: A Registry-Based Cohort Study
por: Sriskandarajah, Sanjeevan, et al.
Publicado: (2017)

Systematic Histological Scoring Reveals More Prominent Interstitial Inflammation in Myeloperoxidase-ANCA Compared to Proteinase 3-ANCA Glomerulonephritis
por: Hakroush, Samy, et al.
Publicado: (2021)

The role of myeloperoxidase and myeloperoxidase–antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis
por: Arimura, Yoshihiro, et al.
Publicado: (2013)

Utilizing the MEST score for prognostic staging in IgA nephropathy
por: Haaskjold, Yngvar Lunde, et al.
Publicado: (2022)

Circulating immune-complexes and complement activation through the classical pathway in myeloperoxidase-ANCA-associated glomerulonephritis
por: Kojima, Tadasu, et al.
Publicado: (2022)

Exploring Frequencies of Circulating Specific Th17 Cells against Myeloperoxidase and Proteinase 3 in ANCA Associated Vasculitis
por: Martinez Valenzuela, Laura, et al.
Publicado: (2019)

Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis
por: Hakroush, Samy, et al.
Publicado: (2021)

Differences between myeloperoxidase-antineutrophil cytoplasmic autoantibody (ANCA) and proteinase 3-ANCA associated vasculitis: A retrospective study from a single center in China
por: Wu, Ting, et al.
Publicado: (2021)

Validation of two IgA nephropathy risk-prediction tools using a cohort with a long follow-up
por: Haaskjold, Yngvar Lunde, et al.
Publicado: (2022)

Long-term follow-up of IgA nephropathy: clinicopathological features and predictors of outcomes
por: Haaskjold, Yngvar Lunde, et al.
Publicado: (2023)

A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathy
por: Shimada, Michiko, et al.
Publicado: (2013)

High prevalence of Chlamydophila pneumoniae infection in patients with myeloperoxidase antineutrophil cytoplasmic autoantibody (MPO-ANCA)-associated glomerulonephritis
por: Kawaguchi, Takehiko, et al.
Publicado: (2008)

A Rare Case of Pulmonary-Renal Syndrome With Triple-Seropositive for Myeloperoxidase-Anti-Neutrophil Cytoplasm Antibody (MPO-ANCA), Proteinase 3 (PR3)-ANCA and Anti-Glomerular Basement Membrane (GBM) Antibodies
por: Palha, Vanessa, et al.
Publicado: (2021)

The C3aR promotes macrophage infiltration and regulates ANCA production but does not affect glomerular injury in experimental anti-myeloperoxidase glomerulonephritis
por: Dick, Jonathan, et al.
Publicado: (2018)

The performance of the chemiluminescent immunoassay for measuring serum myeloperoxidase and proteinase 3 antibodies
por: Hou, Xiuzhu, et al.
Publicado: (2020)

Characterization of the CD177 interaction with the ANCA antigen proteinase 3
por: Jerke, Uwe, et al.
Publicado: (2017)

Epitope Analysis of Anti-Myeloperoxidase Antibodies in Patients with ANCA-Associated Vasculitis
por: Gou, Shen-Ju, et al.
Publicado: (2013)

Evaluation of the newly proposed simplified histological classification in Japanese cohorts of myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in comparison with other Asian and European cohorts
por: Muso, Eri, et al.
Publicado: (2012)

Patient Survival Between Hemodialysis and Peritoneal Dialysis Among End-Stage Renal Disease Patients Secondary to Myeloperoxidase-ANCA-Associated Vasculitis
por: Wu, Xueqin, et al.
Publicado: (2022)

Assessment of Renal Risk Score and Histopathological Classification for Prediction of End-Stage Kidney Disease and Factors Associated With Change in eGFR After ANCA-Glomerulonephritis Diagnosis
por: Brilland, Benoit, et al.
Publicado: (2022)

A case report of PR-3-ANCA-positive glomerulonephritis with histological features of GPA associated with infectious endocarditis
por: Hirata, Momoko, et al.
Publicado: (2021)

ANCA negative pauci-immune glomerulonephritis with systemic involvement
por: Sampathkumar, K., et al.
Publicado: (2010)

Crescentic Glomerulonephritis with Anti-GBM and p-ANCA Antibodies
por: Javed, Tariq, et al.
Publicado: (2012)

ANCA-positive pauci-immune glomerulonephritis and febuxostat treatment
por: Izzedine, Hassane, et al.
Publicado: (2012)

Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis
por: Syed, Rafeel, et al.
Publicado: (2015)

ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse
por: Göçeroğlu, Arda, et al.
Publicado: (2016)

MPO-C-ANCA-associated necrotising and crescentic glomerulonephritis
por: Koratala, Abhilash, et al.
Publicado: (2017)

ANCA glomerulonephritis after the Moderna COVID-19 vaccination
por: Sekar, Arjun, et al.
Publicado: (2021)

What is the prognosis of ANCA-associated glomerulonephritis with immune deposition?
por: Xiao, Xiang, et al.
Publicado: (2022)

MPO-ANCA Rapidly Progressive Glomerulonephritis with Immune Deposits
por: Acosta, Eric, et al.
Publicado: (2022)

Improved prognosis in Norwegian patients with glomerulonephritis associated with anti-neutrophil cytoplasmic antibodies
por: Sriskandarajah, Sanjeevan, et al.
Publicado: (2015)

Fibrillary Glomerulopathy with a High Level of Myeloperoxidase-ANCA: A Case Report
por: Asakawa, Tomohiko, et al.
Publicado: (2020)

pANCA autoantibody testing by indirect immunofluorescence indicates interstitial arteritis independent of MPO-ANCA immunoassays in ANCA-associated glomerulonephritis
por: Hakroush, Samy, et al.
Publicado: (2022)

Idiopathic lung fibrosis and anti myeloperoxidase glomerulonephritis: the tree that hides the forest
por: Pineton de Chambrun, Marc, et al.
Publicado: (2015)

Myeloperoxidase to Risk Stratify Emergency Department Patients with Chest Pain
por: Manini, Alex F., et al.
Publicado: (2009)

Renal histopathological predictors of end-stage kidney disease in ANCA-associated vasculitis with glomerulonephritis: a single-centre study in Korea
por: Choi, Sung-Eun, et al.
Publicado: (2023)

Membranous Nephropathy with Proteinase 3-ANCA-associated Vasculitis Successfully Treated with Rituximab
por: Yoshida, Shun, et al.
Publicado: (2020)

Systemic-onset juvenile rheumatoid arthritis and ANCA-associated glomerulonephritis
por: Belot, A, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_65k1p2kb20jskq6n6cpatgrjdk